Admission Date:  [**2172-6-25**]              Discharge Date:   [**2172-9-17**]  Date of Birth:  [**2133-11-20**]             Sex:   F  Service: OBSTETRICS/GYNECOLOGY  Allergies: Penicillins / Heparin Agents  Attending:[**First Name3 (LF) 7141**] Chief Complaint: postcoital bleeding  Major Surgical or Invasive Procedure: 1. exploratory laparotomy, periaortic lymph node dissection, supralevator pelvic exenteration, ileal ureteral conduit + redo with side-side reanastomsis (by GU), sigmoid neovagina (by Plastics), low rectal anastamosis, J-flap omentopexy with transverse loop colostomy 2. re-exploration, repair of ileal conduit, rigid rectosigmoidoscopy 3. exploratory lapartomy for partial abd closure with [**State 19827**] patch, maturation of colostomy, tracheostomy 4. exploratory laparotomy, washout and total abdominal closure with mesh 5. reexploration of abdomen, cauterization of perforating vessel 6.
Thoracentesis 7.
Drainage of pelvic collection with pigtail catheter 8.
Left percutaneous nephrostomy tube placement   History of Present Illness: This is a 38 yo G3P1021 s/p radical hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy on [**2171-10-15**] for Stage Ib1 endometrioid adenocarcinoma of the cervix, s/p 6 cycles of cisplatin and pelvic radiation for involvement of two regional lymph nodes, who presented with vaginal bleeding.
A Pap smear and biopsy of a right vaginal apex thickening on [**2172-5-21**] revealed recurrent adenocarcinoma.
Tumor Board recommendation on [**2172-6-12**] was for total pelvic exenteration.
Past Medical History: cervical CA s/p exploratory laparotomy, radical hysterectomy, bilateral salpingoopherectomy and lymph node dissection [**10/2171**], s/p cisplatin/pelvic radiation; chronic back pain; breast reduction 3/[**2169**].
Brief Hospital Course: On [**2172-6-25**], the patient underwent exploratory laparotomy, periaortic lymph node sampling, supralevator total pelvic exenteration, low rectal anastomosis, J-flap omentopexy, transverse loop colostomy, ileal urinary conduit by the urology service and colonic neovagina reconstruction by plastic surgery service.
Pt was brought to the ICU intubated for postop reovery.
Her antibiotic coverage was changed to cefetime, vancomycin, levofloxacin, metronidazole and fluconazole.
She was started on activated protein C from [**Date range (1) 92378**].
Infectious disease and general surgery was consulted.
Per ID, aspergillus antigen and beta glucan was drawn.
She continued on her antibiotics until [**7-21**], which were discontinued due to negative cultures.
A pigtail catheter was placed [**7-29**] to drain a pelvic collection seen on CT, which also yielded negative cultures.
She was started on levofloxacin and a percutaneous nephrostomy tube placed.
On [**8-27**] vancomycin was started.
She will continue on vancomycin until appointment with infectious disease on [**9-29**].
She will continue on ceftriaxone for a total of 14 day course.
Retention sutures were removed by POD#42 and her wound was packed with wet to dry dressings.
On [**8-17**] her wound was noted to be growing fungus, later identified as aspergillus fumigata; ID was reconsulted and she was started on voriconazole on [**8-18**].
The wound improved and a VAC was placed prior to discharge.
She also had a significant blood loss after her closure on [**7-18**] that required reexploration by general surgery, where 1 L clot was found in the subcutaneous layer.
2 subcutaneous arterial bleeds were identified and cauterized.
She began vaginal dilators on [**8-15**].
Pt was maintained on fentanyl and propofol gtt until [**7-22**].
She was gradually transitioned to PO pain meds with excellent pain control.
CV: Pt required three pressors postoperatively due to septic shock.
She was weaned off pressors by POD#8.
After being transferred to the floor she was tachycardic, which was controlled with metoprolol 100mg [**Hospital1 **].
CT surgery was consulted for possible U/S guided thoracentesis, but the effusions dramatically improved and the thoracentesis was cancelled.
c. Tracheostomy: A tracheostomy was placed by general surgery on [**7-7**].
She was weaned off the ventilator and trach was discontinued [**7-31**].
GI: a. Liver shock: Pt's ALT and AST rose as high as the [**2165**] and her total bilirubin as high as 10 during her septic shock, which slowly resolved over her hospitalization but remained somewhat elevated.
Diet: She was started on TPN and then transitioned to TF when her transverse loop colostomy had output.
She will continue on this medication until her infectious disease apppointment on [**9-29**].
Renal: s/p L ileoureteral conduit repair on [**6-28**] due to leak.
Ureteral stents were removed [**7-15**].
A percutaneous nephrotomy tube was placed [**8-9**].
[**9-3**] nephrogram was done which showed a stricture in the left ureter.
She was started on Epogen and Fe supplementation on [**8-11**] c. Coagulopathy: likely from sepsis.
Heparin was stopped and she was started on lepirudin.
Once her abdomen was closed, she was started on fondaparinux.
She was discharged to acute rehab on POD #83  Medications on Admission: none  Discharge Medications: 1.
Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed.
Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q4-6H (every 4 to 6 hours) as needed for anxiety, before walking.
Dolasetron Mesylate 12.5 mg IV Q8H:PRN 5.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO TID (3 times a day).
Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Acetaminophen-Caff-Butalbital [**Medical Record Number 3668**] mg Tablet Sig: One (1) Tablet PO Q4-6H (every 4 to 6 hours) as needed for HA.
Epoetin Alfa 10,000 unit/mL Solution Sig: One (1)  Injection QMOWEFR (Monday -Wednesday-Friday).
Conjugated Estrogens 0.625 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Voriconazole 200 mg Tablet Sig: 1.5 Tablets PO Q12H (every 12 hours).
Fondaparinux 2.5 mg/0.5 mL Syringe Sig: One (1) Subcutaneous DAILY (Daily).
Acyclovir 5 % Ointment Sig: One (1) Appl Topical  prn as needed for cold sore.
Vancomycin  Intravenous 1250mg q 12 hours   Discharge Disposition: Extended Care  Facility: [**Hospital3 1107**] [**Hospital **] Hospital - [**Location (un) 38**]  Discharge Diagnosis: recurrent cervical cancer septic shock aspergillus wound infection serratia urinary tract infection pelvic abscess left ureteral stricture   Discharge Condition: stable  Discharge Instructions: Acute Rehab  Followup Instructions: General Surgery: Please follow up with Dr. [**First Name (STitle) 2819**] in surgery clinic in early [**Month (only) **].
[**Telephone/Fax (1) 5777**]  Call to schedule appointment  Provider: [**Last Name (NamePattern4) **].
